PATENT CLAIM ANALYSIS

Application Number: 15891846
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["546", "119000"]

Abstract:
The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I or IA to a patient in need thereof:

Claim (Index 15):
The compound of  claim 11  having the formula or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 88.0
- Lexical Diversity: 1.46429
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14876428', '15409991', '14210232', '14210277', '15602892']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.77319832188146
- 35 USC 102 Novelty (BERT): 0.521929489233394
- Combined Prediction Score: 0.7480714386166534
- Mean Citation Score: 293.135576
- Max Citation Score: 324.80426
- Similarity Product: 272.31862336619736

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test